News

Find updates on the work of our researchers here, as well as news about recent advances in Alzheimer's science, funding and awareness.

Art and Alzheimer's: Tim Armour on WGBH

In recent years, depictions of dementia on the stage and screen have become increasingly common. On February 20, 2014, Cure Alzheimer's Fund president and CEO Tim Armour appeared on WGBH News to discuss art and Alzheimer's disease. He was joined by WGBH arts editor Jared Bowen to talk about a recent play, "Absence", which tells the story of a woman living with dementia through her own eyes.

Support Cure Alzheimer's Fund with the Boston Globe

Are you a Boston Globe subscriber? If so, we ask you to support Cure Alzheimer's Fund through the brand new GRANT program (Globe Readers And Non-profits Together). Using this program, you can help us to gain free advertising space in the Globe newspaper at no cost to you.

Drug Development Strategy: Three Points of Attack

In view of an emerging consensus on how Alzheimer’s disease develops and progresses, the Cure Alzheimer’s Fund Research Consortium aggressively is focusing on three opportunities for possible intervention—at the early stage of the disease, the middle stage and the late stage. This comprehensive strategy addresses the whole picture of how Alzheimer’s disease develops and progresses, and attacks all three points simultaneously.

Meet Thomas Südhof, M.D.

When Dr. Thomas Südhof first learned he had won the Nobel Prize last October, he could not have been more surprised. “Are you serious?” were the first words out of his mouth.  

From Alzheimer's Research to Aerosmith: Rudy Tanzi on Creativity in Science and Music

For PBS's series "The Secret Life of Scientists and Engineers", Rudy Tanzi, Ph.D., talks about his life-long love of music.

Increasing Public Understanding of Alzheimer’s in Stuart, Florida

Increasing public understanding of Alzheimer’s disease is the goal of two free screenings of “The Genius of Marian” (right), featured at the 2013 Tribeca Film Festival, and a presentation by leading Alzheimer’s researcher and chair of the Cure Alzheimer’s Fund Research Consortium, Rudy Tanzi, Ph.D. Both events are co-sponsored through Cure Alzheimer’s

Stem Cell Model of Familial Alzheimer's Identifies New AD Genes

A stem cell model of familial Alzheimer’s disease (FAD) was successfully generated in a recent study, allowing researchers to identify 14 genes potentially implicated in the disease. One gene in particular demonstrates the important role inflammation may play in the brain of Alzheimer’s patients. The study was completed by scientists at The New York Stem Cell Foundation (NYSCF) Research Institute in collaboration with scientists at the Icahn School of Medicine at Mount Sinai (ISMMS) and funded in part by the Cure Alzheimer’s Fund (CAF).

Living Brain Cells Created from Biobanked Alzheimer's Brain Tissue

Scientists at The New York Stem Cell Foundation (NYSCF) Research Institute, working in collaboration with scientists from Columbia University Medical Center (CUMC), for the first time generated induced pluripotent stem (iPS) cells lines from non-cryoprotected brain tissue of patients with Alzheimer’s disease.

Rudy Tanzi on CBS: How Close is a Treatment for Alzheimer's?

On Saturday, January 4, Rudy Tanzi, Ph.D. appeared on CBS News' This Morning to discuss the current state of research towards an Alzheimer's cure.

In the segment, Tanzi explains some of the reasons behind past drug failures and the ways in which the current generation of drugs in development will hopefully avoid these pitfalls. He also describes preventative measures one can take against the disease, such as healthy diet, exercise, and social engagement.

Circadian Clock Proteins a Potential Therapeutic Target for Alzheimer’s

Brain aging is associated with lower production of circadian clock proteins, which synchronize biological processes to light and dark cycles. In Alzheimer’s and other neurodegenerative diseases, circadian dysfunction is commonly observed.